We provide you with 20 years of free, institutional-grade data for RETA stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of RETA. Explore the full financial landscape of RETA stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| Loewen Andrea | Sale | -3,175 | $172.03 | $546,181 | 2023-09-18 |
| Anand Bhaskar | Sale | -406 | $169.2 | $68,695 | 2023-09-07 |
| WORTLEY MICHAEL D | Sale | -1,205 | $169.04 | $203,692 | 2023-08-17 |
| Soni Manmeet Singh | Sale | -1,755 | $168.41 | $295,566 | 2023-08-17 |
| Meyer Colin John | Sale | -2,740 | $169.07 | $463,248 | 2023-08-17 |
| Bir Dawn Carter | Sale | -1,205 | $169.04 | $203,689 | 2023-08-17 |
| Anand Bhaskar | Sale | -403 | $169.06 | $68,129 | 2023-08-17 |
| Soni Manmeet Singh | Sale | -75,000 | $164.62 | $12,346,298 | 2023-08-01 |
| Soni Manmeet Singh | Conversion | 75,000 | 2023-08-01 | ||
| Soni Manmeet Singh | Derivatives Exercise | 2023-08-01 | |||
| Ruff Shamim | Sale | -8,235 | $164.53 | $1,354,887 | 2023-08-01 |
| Ruff Shamim | Derivatives Exercise | 8,235 | 2023-08-01 | ||
| McClellan William D. Jr. | Sale | -5,000 | $164.49 | $822,442 | 2023-08-01 |
| McClellan William D. Jr. | Conversion | 5,000 | 2023-08-01 | ||
| McClellan William D. Jr. | Derivatives Exercise | 2023-08-01 | |||
| Bir Dawn Carter | Sale | -40,000 | $164.54 | $6,581,428 | 2023-08-01 |
| Bir Dawn Carter | Conversion | 40,000 | 2023-08-01 | ||
| Bir Dawn Carter | Derivatives Exercise | 2023-08-01 | |||
| WORTLEY MICHAEL D | Grant, award...etc | 4,125 | 2023-07-10 | ||
| Soni Manmeet Singh | Grant, award...etc | 6,000 | 2023-07-10 | ||
| Meyer Colin John | Grant, award...etc | 6,000 | 2023-07-10 | ||
| Bir Dawn Carter | Grant, award...etc | 4,125 | 2023-07-10 | ||
| Huff James Warren | Grant, award...etc | 84,220 | 2023-07-10 | ||
| Anand Bhaskar | Sale | -2,343 | $102.11 | $239,248 | 2023-06-16 |
| Anand Bhaskar | Derivatives Exercise | 1,562 | 2023-06-16 | ||
| Soni Manmeet Singh | Derivatives Exercise | 25,000 | 2023-06-14 | ||
| Soni Manmeet Singh | Sale | -82,796 | $99.62 | $8,247,914 | 2023-06-14 |
| Patni Rajiv | Grant, award...etc | 45,000 | 2023-06-14 | ||
| Edwards Martin | Grant, award...etc | 1,815 | $93.61 | 2023-06-09 | |
| McClellan William D. Jr. | Grant, award...etc | 1,788 | $93.61 | 2023-06-09 | |
| Ruff Shamim | Grant, award...etc | 2,136 | $93.61 | 2023-06-09 | |
| Oliger Christy J. | Grant, award...etc | 1,682 | $93.61 | 2023-06-09 | |
| Ryder Steven | Grant, award...etc | 2,029 | $93.61 | 2023-06-09 | |
| Soni Manmeet Singh | Sale | -22,132 | $84.32 | $1,866,172 | 2023-05-17 |
| WORTLEY MICHAEL D | Sale | -1,311 | $84.81 | $111,179 | 2023-05-17 |
| Meyer Colin John | Sale | -6,233 | $84.76 | $528,289 | 2023-05-17 |
| Anand Bhaskar | Sale | -1,086 | $85.98 | $93,378 | 2023-05-17 |
| Khan Samina | Sale | -640 | $85.32 | $54,605 | 2023-05-17 |
| Bir Dawn Carter | Sale | -1,311 | $85.09 | $111,553 | 2023-05-17 |
| Loewen Andrea | Sale | -7,166 | $86.26 | $618,152 | 2023-05-16 |
| Soni Manmeet Singh | Grant, award...etc | 50,000 | 2023-05-09 | ||
| Bir Dawn Carter | Sale | -9,317 | $86.77 | $808,436 | 2023-03-15 |
| Ruff Shamim | Sale | -5,740 | $83.73 | $480,610 | 2023-03-13 |
| Ruff Shamim | Derivatives Exercise | 5,740 | 2023-03-13 | ||
| Loewen Andrea | Sale | -19,036 | $83.36 | $1,586,841 | 2023-03-09 |
| Loewen Andrea | Derivatives Exercise | 15,000 | 2023-03-09 | ||
| WORTLEY MICHAEL D | Sale | -414 | $84.46 | $34,966 | 2023-03-08 |
| Khan Samina | Sale | -3,961 | $83.46 | $330,585 | 2023-03-08 |
| Bir Dawn Carter | Conversion | 90,000 | 2023-03-08 | ||
| Bir Dawn Carter | Derivatives Exercise | 0 | 2023-03-08 | ||
| Bir Dawn Carter | Sale | -96,996 | $89.3 | $8,661,743 | 2023-03-08 |
| Meyer Colin John | Sale | -621 | $84.57 | $52,518 | 2023-03-08 |
| Anand Bhaskar | Sale | -165 | $84.58 | $13,956 | 2023-03-08 |
| Soni Manmeet Singh | Sale | -622 | $84.69 | $52,680 | 2023-03-08 |
| Meyer Colin John | Conversion | 88,636 | 2023-03-06 | ||
| Meyer Colin John | Derivatives Exercise | 2023-03-06 | |||
| Meyer Colin John | Sale | -93,922 | $85.23 | $8,004,972 | 2023-03-06 |
| WORTLEY MICHAEL D | Sale | -2,169 | $87.57 | $189,939 | 2023-03-06 |
| Soni Manmeet Singh | Sale | -3,587 | $87.97 | $315,548 | 2023-03-06 |
| Loewen Andrea | Sale | -1,819 | $90.61 | $164,820 | 2023-03-06 |
| Khan Samina | Sale | -27,813 | $83.7 | $2,327,948 | 2023-03-06 |
| Khan Samina | Derivatives Exercise | 25,000 | 2023-03-06 | ||
| Anand Bhaskar | Sale | -820 | $87.47 | $71,725 | 2023-03-06 |
| Bir Dawn Carter | Sale | -2,166 | $88.25 | $191,148 | 2023-03-06 |
| Huff James Warren | Sale | -75,000 | $81.49 | $6,111,750 | 2023-03-03 |
| Huff James Warren | Conversion | 75,000 | 2023-03-03 | ||
| Anand Bhaskar | Grant, award...etc | 3,000 | 2023-03-02 | ||
| Meyer Colin John | Grant, award...etc | 15,000 | 2023-03-01 | ||
| Huff James Warren | Grant, award...etc | 47,025 | 2023-01-04 | ||
| Soni Manmeet Singh | Grant, award...etc | 23,513 | 2023-01-04 | ||
| Meyer Colin John | Grant, award...etc | 23,513 | 2023-01-04 | ||
| WORTLEY MICHAEL D | Grant, award...etc | 15,675 | 2023-01-04 | ||
| Loewen Andrea | Grant, award...etc | 11,756 | 2023-01-04 | ||
| Khan Samina | Grant, award...etc | 11,756 | 2023-01-04 | ||
| Bir Dawn Carter | Grant, award...etc | 15,675 | 2023-01-04 | ||
| Anand Bhaskar | Grant, award...etc | 8,250 | 2023-01-04 | ||
| Ryder Steven | Grant, award...etc | 8,878 | $32.36 | 2022-07-12 | |
| Oliger Christy J. | Grant, award...etc | 3,883 | $34.76 | 2022-06-09 | |
| Ruff Shamim | Grant, award...etc | 5,105 | $34.76 | 2022-06-09 | |
| McClellan William D. Jr. | Grant, award...etc | 4,170 | $34.76 | 2022-06-09 | |
| Edwards Martin | Grant, award...etc | 4,242 | $34.76 | 2022-06-09 |
The information provided in this report about RETA stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Reata Pharmaceuticals, Inc(NASDAQ:RETA) 
Reata Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops novel therapeutics for patients with serious or life-threatening diseases by targeting molecular pathways that regulate cellular metabolism and inflammation. The company is developing Phase III clinical trial programs,...
Website: http://www.reatapharma.com
Founded: 2002
Full Time Employees: 220
Sector: Healthcare
Industry: Biotechnology